Skip to main content
Premium Trial:

Request an Annual Quote

Bayer Schering Pharma, Prometheus Reach Agreement on Oncology Mutational Analyses

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Prometheus Laboratories and Bayer Schering Pharma today said they have executed an oncology-focused mutational analyses services agreement, building on a deal reached between the two parties earlier this year.

Information gleaned from the new agreement may lead to better patient stratification in clinical studies and hasten the development of new cancer diagnostics and treatments, Prometheus said in a statement.

Under the deal, Bayer will provide samples that have been sourced from clinical trials. Prometheus will carry out mutational analyses to characterize the presence or absence of mutations in the samples that may be associated with cancer.

Bayer will pay Prometheus for each mutational analysis it performs, with payment amounts based on the complexity of the analysis. No further financial details of the deal were disclosed.

In March, the two companies entered a research collaboration and licensing agreement bringing together Prometheus' oncology diagnostic CEER platform and Bayer's extensive oncology pipeline. The goal of the deal, which could net Prometheus as much as $160 million, is to develop tools to stratify patients and direct them to the correct drug treatment, and to accelerate the development of new oncology diagnostics and therapeutics.

The CEER platform measures the expression and activation of specific cancer pathways using blood or tissue samples.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.